auto-fix: strip 4 broken wiki links

Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.

domains/health/only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constraint.md

@@ -29,12 +29,12 @@ The JACC study tracking 1999-2023 NHANES data reveals a striking failure mode in
 The population-level outcome of poor blood pressure control manifests as doubled hypertensive disease mortality 2000-2023, with 664,000 deaths in 2023 where hypertension was primary or contributing cause. Middle-aged adults (35-64) showed the most pronounced increases, indicating the treatment failure compounds over working-age years.
 
 ### Additional Evidence (challenge)
-*Source: [[2024-09-xx-pmc-equity-digital-health-rpm-wearables-underserved-communities]] | Added: 2026-03-31*
+*Source: 2024-09-xx-pmc-equity-digital-health-rpm-wearables-underserved-communities | Added: 2026-03-31*
 
 Digital health is frequently proposed as a solution to the hypertension control failure, but Adepoju et al. (2024) show that generic RPM deployment reproduces existing disparities. Despite high smartphone ownership in underserved populations, medical app usage was significantly lower among those with income below $35,000 and education below bachelor's degree. Barriers included data plan costs, poor connectivity, health literacy gaps, and transportation requirements for onboarding—meaning RPM requires the same access infrastructure it's supposed to bypass. The Affordability Connectivity Program that subsidized broadband for low-income households was discontinued June 2024, removing the primary federal mitigation.
 
 ### Additional Evidence (extend)
-*Source: [[2024-06-xx-aha-hypertension-sdoh-systematic-review-57-studies]] | Added: 2026-03-31*
+*Source: 2024-06-xx-aha-hypertension-sdoh-systematic-review-57-studies | Added: 2026-03-31*
 
 The systematic review establishes that the binding constraints are SDOH-mediated: housing instability affects treatment adherence, transportation barriers prevent care access, food insecurity directly increases hypertension prevalence, and insurance gaps reduce BP control. The review endorses CMS's HRSN screening tool (housing, food, transportation, utilities, safety) as a necessary hypertension care component.
 

inbox/queue/2025-07-09-medrxiv-kentucky-mtm-grocery-prescription-bp-reduction-9mmhg.md

@@ -50,8 +50,8 @@ Preprint posted July 9, 2025 on medRxiv. Not yet peer-reviewed.
 **KB connections:**
 - From Session 16: SDOH five-factor review (food insecurity independently predicts HTN non-control) — this study is the intervention test of that mechanism
 - AHA Boston Food is Medicine study (Session 17, archived): -9.67 mmHg effect size likely appears during active delivery, but AHA Boston showed reversion at 6 months
-- [[GLP-1 receptor agonists — largest therapeutic category launch]]: GLP-1's BP reduction is typically 1-3 mmHg systolic in clinical trials — the MTM food intervention achieves 3-9x the BP reduction of GLP-1 in this population
-- [[value-based care transitions stall at the payment boundary]]: This is an unlicensed, unreimbursed intervention producing better outcomes than drugs that ARE reimbursed
+- GLP-1 receptor agonists — largest therapeutic category launch: GLP-1's BP reduction is typically 1-3 mmHg systolic in clinical trials — the MTM food intervention achieves 3-9x the BP reduction of GLP-1 in this population
+- value-based care transitions stall at the payment boundary: This is an unlicensed, unreimbursed intervention producing better outcomes than drugs that ARE reimbursed
 
 **CLAIM CANDIDATE:**
 "Medically tailored meals produce -9.67 mmHg systolic BP reductions in food-insecure hypertensive patients — comparable to or exceeding first-line pharmacotherapy — suggesting dietary intervention at the level of structural food access is a clinical-grade treatment for hypertension in food-burdened populations"